Intrauterine Adhesion Clinical Trial
Official title:
Prevention of Postoperative Adhesion Recurrence by Estrogen-intrauterine Stent System
NCT number | NCT04972032 |
Other study ID # | E-IUS |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | September 2, 2020 |
Est. completion date | March 2025 |
This is a prospective, randomized, single-blinded,multi-center trial to compare the efficacy of an Estrogen-intrauterine stent system with foley balloon combined with intrauterine cross-linked sodium hyaluronate gel in the prevention of intrauterine adhsion recurrence after hysteroscopic adhesiolysis.
Status | Recruiting |
Enrollment | 246 |
Est. completion date | March 2025 |
Est. primary completion date | March 2024 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 40 Years |
Eligibility | Inclusion Criteria: - Female patients aged 18-40 years; - Meets the diagnostic criteria for moderate to severe uterine adhesions; - Has the indication for TCRA surgery and is intending to undergo TCRA surgery; - Female subjects are not breastfeeding at the time of the screening visit; ? Voluntary acceptance of the treatment and has signed the informed consent form. Exclusion Criteria: - Known allergic reactions to or contraindications for silicone rubber materials, estradiol and its metabolites, Foley balloon catheters and/or intrauterine cross-linked sodium hyaluronate gel; - Presence of contraindications for TCRA surgery; - Requires oral hormonal medications for a prolonged period of time; - Has used high-dose estrogen medication within one month prior to surgery; - Suffering from diseases such as genital tract tuberculosis, acute genital tract inflammation, pelvic inflammatory disease, abnormal uterine bleeding caused by systemic disease or malignant tumours of the genital organs; ? Perimenopausal and menopausal females; ? Comorbid with severe primary diseases of the cardiovascular, cerebrovascular, hepatic, renal or hematopoietic system, or peptic ulcer disease, or severe diseases affecting patient survival (such as tumours or AIDS), or mental illness; ? Drug or alcohol dependence; ? Has enrolled in other clinical trials within the last 1 month; ? Patients with factors considered by the investigators to be unsuitable for enrollment. |
Country | Name | City | State |
---|---|---|---|
China | YiPuRun (Shanghai) Biotechnology Co.,Ltd. | Shanghai | Shanghai |
Lead Sponsor | Collaborator |
---|---|
Limin Feng |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Post-operative adhesion recurrence rate(%) | The severity of adhesion will be assessed by hysteroscopy before and on d60 after surgery using the America Fertility Score (AFS) system. If the AFS score on D60 second-look hysteroscopy over 0 will be considered as adhesion recurrence. Post-operative adhesion recurrence rate(%)=(patients whose AFS score >0-point after surgery/All patients after surgery)X100%. The recurrence rate (%) is range from 0(Mini) to 100(Max).The lower the recurrence means the patient has a better post-operative outcome. | 60 days | |
Secondary | Menstrual improvement rate %(PBAC score) | Menstrual improvement rate (evaluated by PBAC score) on 60 days after surgery | 60 days | |
Secondary | Pregnancy rate% | Pregnancy rate%=Number of patients with successful Pregnancy /Number of all patients)X100% | 1-2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03381807 -
Human Amniotic Epithelial Stem Cell in Treatment of Refractory Severe Intrauterine Adhesion
|
Early Phase 1 | |
Recruiting |
NCT03329898 -
Comparing the Efficacy of Two Methods for the Therapy of Uterine Adhesion
|
N/A | |
Completed |
NCT03724617 -
Clinical Study of Umbilical Cord Mesenchymal Stem Cells Combined With Collagen Scaffold in the Treatment of Thin Endometrium
|
N/A | |
Recruiting |
NCT03330873 -
The Efficacy and Safety of Disposable Balloon Uterine Stent in Patients With Asherman Syndrome
|
N/A | |
Completed |
NCT02220621 -
Efficacy and Safety of Crosslinked Hyaluronan Gel for Preventing Intrauterine Adhesion
|
N/A | |
Active, not recruiting |
NCT04963179 -
PREvention of Intrauterine Adhesion After Adhesiolysis With Novel Tri-block deGradable Polymer Film.
|
N/A | |
Recruiting |
NCT03351205 -
The Efficacy of Estrogen Therapy Against Adhesion Reformation After Hysteroscopic Adhesiolysis
|
N/A | |
Completed |
NCT04381728 -
PREvention of Intrauterine Adhesion After Hysteroscopic Surgery With Novel deGradable Film
|
N/A | |
Recruiting |
NCT03346317 -
Comparing the Efficacy of Two Methods in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis
|
N/A | |
Completed |
NCT05414760 -
Evaluate Formation of IUAs After Third-generation Endometrial Ablation, With and Without Intrauterine Adhesion Barrier
|
N/A | |
Completed |
NCT04166500 -
Early Outpatient Hysteroscopy Can Prevent Intrauterine Adhesion After Induced Abortion
|
N/A | |
Recruiting |
NCT03171454 -
Immediate and Delayed Intrauterine Balloon in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis
|
N/A | |
Recruiting |
NCT03169478 -
Intrauterine Balloon Dilatation Therapy in the Prevention of Adhesion Formation After Hysteroscopic Myomectomy
|
N/A | |
Recruiting |
NCT05003869 -
Clinical and Basic Research on the Necessity of Scar Tissue Resection During Intrauterine Adhesions
|
N/A | |
Completed |
NCT02744716 -
Effects of Aspirin on Uterine Endometrial Repair Severe Intrauterine Adhesion
|
N/A | |
Completed |
NCT03131596 -
Postoperative Intermittent Intrauterine Balloon Dilatation Therapy.
|
N/A | |
Completed |
NCT04824430 -
Assessment of Uterine Access, Uterine Patency and Intrauterine Adhesions Following Endometrial Ablation
|
||
Completed |
NCT01167296 -
Safety of Leaving Cook Balloon Uterine Stent in Uterus for One Month
|
Phase 4 | |
Completed |
NCT03578172 -
HMG Stimulation Versus HRT for Endometrial Preparation Prior to Blastocyst Transfer in Moderate to Severe IUA Patients
|
N/A | |
Recruiting |
NCT04930913 -
Three-dimensional Ultrasound Applying in Assessment of Intrauterine Adhesions
|